drug · small molecule
patient view →ASP-001.1
Phase 1updated 2mo agoby Aspargo Laboratories Inc🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 30 investigational indications.
targets
cGMP-specific 3',5'-cyclic phosphodiesterase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that